CN109619559A - A kind of preparation method and production technology of fresh American ginseng buccal tablet - Google Patents
A kind of preparation method and production technology of fresh American ginseng buccal tablet Download PDFInfo
- Publication number
- CN109619559A CN109619559A CN201811560942.XA CN201811560942A CN109619559A CN 109619559 A CN109619559 A CN 109619559A CN 201811560942 A CN201811560942 A CN 201811560942A CN 109619559 A CN109619559 A CN 109619559A
- Authority
- CN
- China
- Prior art keywords
- fresh
- american ginseng
- buccal tablet
- ginseng
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 108
- 240000005373 Panax quinquefolius Species 0.000 title claims abstract description 86
- 229940046011 buccal tablet Drugs 0.000 title claims abstract description 25
- 239000006189 buccal tablet Substances 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 238000005516 engineering process Methods 0.000 title description 3
- 238000004519 manufacturing process Methods 0.000 title description 3
- 239000000843 powder Substances 0.000 claims abstract description 30
- 241000208340 Araliaceae Species 0.000 claims abstract description 23
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 23
- 235000008434 ginseng Nutrition 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 8
- 238000001694 spray drying Methods 0.000 claims abstract description 8
- 241000196324 Embryophyta Species 0.000 claims abstract description 7
- 235000019871 vegetable fat Nutrition 0.000 claims abstract description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims abstract description 6
- 229920002678 cellulose Polymers 0.000 claims abstract description 4
- 239000001913 cellulose Substances 0.000 claims abstract description 4
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims abstract description 3
- 235000019341 magnesium sulphate Nutrition 0.000 claims abstract description 3
- 239000002002 slurry Substances 0.000 claims description 23
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 claims description 13
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 claims description 6
- 239000007937 lozenge Substances 0.000 claims description 5
- 239000000835 fiber Substances 0.000 claims description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 4
- 238000000265 homogenisation Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000000084 colloidal system Substances 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 230000014759 maintenance of location Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 229920001661 Chitosan Polymers 0.000 claims 1
- 229920001202 Inulin Polymers 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims 1
- 229940029339 inulin Drugs 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract description 12
- 238000000034 method Methods 0.000 abstract description 9
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract 2
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000012545 processing Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 5
- 239000013558 reference substance Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000003672 processing method Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- -1 Organic acid Polysaccharide Chemical class 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000019628 coolness Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000011003 system suitability test Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000008542 thermal sensitivity Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to the field of Chinese medicines, and in particular to a kind of fresh American ginseng buccal tablet and preparation method thereof.The fresh American ginseng buccal tablet is made of a variety of or a kind of raw material, by weight percentage, above-mentioned plurality of raw materials includes fresh ginseng powder 50-100%, water-soluble cellulose 0-10%, corrigent 0-1% or more, vegetable fat powder 0-40%, citric acid 0-2%, plant polyose 0-10% magnesium sulfate 0-1%, magnesium stearate 0-1%, then by adding the processes such as water grinding, homogeneous, spray drying to be prepared into fresh ginseng powder, then tabletting both fresh American ginseng buccal tablet, conducive to carry, conveniently take, loss of effective components is few, absorption is fast, bioavilability is high the features such as.
Description
Technical field
The present invention relates to health food manufacture field, the processing method for being specifically related to a kind of fresh American ginseng buccal tablet.
Background technique
Traditional Chinese medicine American ginseng is the dry root of Panax quinquefolium L. of araliaceae Panax quinquefolium L.This product has
Boosting qi and nourishing yin, clearing heat and promoting fluid.Clinic is usually used in deficiency of vital energy yin deficiency, and abnormal heat is tired of tired, cough and asthma phlegm blood, Heat Diabetes, dryness of the mouth and throat etc.
Treatment.The processing method of traditional American Ginseng are as follows: after excavating medicinal material, clean, sun drying or low temperature drying, be packaged, storage and transportation.The side of taking
Method be divided into boil, stew, steamed wheaten foods, slice are containing changing, be ground into subdivision and take after mixing it with water.
Current commercial American Ginseng finely processed product is by sunning mostly, the product that techniques are produced such as toasts or boil,
Since its thermal sensitivity functional mass is more easily damaged under high temperature environment, or the content of functional component is reduced, keeps American Ginseng effective
Ingredient such as American ginseng saponin, polysaccharide, protein, active enzyme polypeptide, volatile component have compared with lossy, American Ginseng physiological activity
It dies down, reduces the quality of American Ginseng product.Existing research show fresh American Ginseng than sun-dried American Ginseng have more activity at
Point, effective component either type or total amount contained by fresh American Ginseng substantially exceed drying American Ginseng.And real feelings
Condition is that fresh American Ginseng is fresh-keeping due to being difficult to, and often directly sun-dried or drying saves.
Currently, being directed to American Ginseng food products market, there are no a kind of processing and antistaling technologies, and fresh American Ginseng can be made processed
After processing, remain to fresh-keeping and do not lose nutrition, but can accomplish to be convenient for carrying, is convenient to take, ingredient draws are fast, biological utilisation
Degree is high, and the present invention researchs and proposes in view of the deficiencies of the prior art.
Summary of the invention
It is an object of the invention to be directed to the deficiency of existing fresh American Ginseng processing method for keeping fresh, a kind of fast rapid-curing cutback of energy is provided
It is dry fresh-keeping, and the nutriment of American Ginseng through processing is able to the method saved from damage, the method for the present invention has short flow, raw
It is fast to produce speed, the low feature of processing cost, while American Ginseng through processing is with easy to carry, ingredient draws are fast, biology benefit
The high feature of expenditure.
The present invention provides a kind of preparation method of fresh American ginseng buccal tablet, the weight percent of the component of fresh American ginseng buccal tablet
Are as follows: fresh ginseng powder 60-100%, water-soluble cellulose 0-10%, corrigent 0-1% or more, vegetable fat powder 0-40%, organic acid 0-2%,
Plant polyose 0-10%, magnesium sulfate 0-1%, magnesium stearate 0-1%.Preparation method including the following steps:
Step 1): the full fresh American Ginseng of juice is selected, cut into serving pieces, slice thickness 3-5cm are cleaned；
Step 2): the ratio of fresh American Ginseng and water is put into colloid mill according to the ratio of 1:2-8, is beaten, fresh American Ginseng slurry is obtained
Liquid, such as water-soluble fibre, corrigent, vegetable fat powder, citric acid, plant polyose component must be added, it can be first by these component water
It dissolves or adds water and stirs as uniform suspension, then be beaten together with fresh American Ginseng；
Step 3): the fresh American Ginseng slurries in step 2 are crossed into homogenizer, the pressure of homogeneous is 0-10 megapascal, and homogenization cycles are
2-3 times, the fresh American Ginseng slurries after obtaining homogeneous；
Step 4): American Ginseng slurries fresh in step 3 are crossed into high pressure homogenizer, the pressure of homogeneous is 50-500 megapascal, obtains height
Fresh American Ginseng slurries after pressing homogeneous, fresh American Ginseng slurries obtain fresh ginseng powder through low temperature spray drying, and spray drying goes out
Draught temperature is controlled at 30-50 DEG C.
Step 5): by fresh ginseng powder relative humidity be 0~20% environment discharge, then tabletting both fresh the West
Join lozenge.
Compared with prior art, the invention has the following beneficial effects:
1. liang step homogeneous, first low pressure can guarantee the fluency in homogenizing process in high pressure, and can guarantee product particle size
Uniformly, and particle diameter reaches between 10-200nm, ensure that the feature that the absorption of product is fast and bioavilability is high.
2. using the method for the present invention, the distinctive many effumabilities of script in fresh American Ginseng can be made, to thermo-responsive natural
Functional component remains well, and retains the shape of fresh American Ginseng, distinctive smell, and when being obviously shortened processing
Between, reduce processing cost, extend the quality guarantee period of fresh American Ginseng, and can accomplish to be convenient for carrying, is convenient to take, ingredient is inhaled
Receive fast, bioavilability height.
Specific embodiment
The present invention is made combined with specific embodiments below and being further described through, but specific embodiment is not the present invention
Any restriction.
The comparison of effective component in the fresh American Ginseng of embodiment 1 and fresh ginseng powder
The fresh American Ginseng of table 1 and no added fresh ginseng powder American ginseng saponin comparison (%)
The fresh American Ginseng of table 2 and no added fresh ginseng powder other compositions comparison (%)
| Ingredient | Organic acid | Polysaccharide | Organized enzyme | Free amino acid |
| Fresh American Ginseng | 1.28% | 27.3 | 0.25 | 7.35 |
| Fresh ginseng powder | 1.29% | 27.1 | 0.26 | 7.27 |
Embodiment 2
The weight percent of the component of fresh American ginseng buccal tablet are as follows: fresh ginseng powder 100%.Preparation method includes following step
It is rapid:
Step 1): the full fresh American Ginseng of juice is selected, cut into serving pieces, slice thickness 3-5cm are cleaned；
Step 2): the ratio of fresh American Ginseng and water is put into colloid mill according to the ratio of 1:5, is beaten, fresh American Ginseng slurry is obtained
Liquid；
Step 3): the fresh American Ginseng slurries in step 2 are crossed into homogenizer, the pressure of homogeneous is 0 megapascal, and homogenization cycles are 3 times,
Fresh American Ginseng slurries after obtaining homogeneous；
Step 4): American Ginseng slurries fresh in step 3 are crossed into high pressure homogenizer, the pressure of homogeneous is 500 megapascal, and it is equal to obtain high pressure
Fresh American Ginseng slurries after matter, fresh American Ginseng slurries obtain fresh ginseng powder, the air outlet of spray drying through low temperature spray drying
At 50 DEG C, the diameter of fresh ginseng powder is 20nm for temperature control.
Step 5): by fresh ginseng powder relative humidity be 20% environment discharge, then tabletting both fresh American Ginseng contains
Piece.
Embodiment 3
The weight percent of the component of fresh American ginseng buccal tablet are as follows: fresh ginseng powder 60%, water-soluble cellulose 10%, corrigent 1% with
On, vegetable fat powder 20%, citric acid 2%, plant polyose 4%, magnesium stearate 1%.Preparation method including the following steps:
Step 1): the full fresh American Ginseng of juice is selected, cut into serving pieces, slice thickness 3-5cm are cleaned；
Step 2): the components such as water-soluble fibre, corrigent, vegetable fat powder, citric acid, plant polyose add according to the ratio of 1:8
Enter water, first these component water are dissolved or are added water and stirred as uniform suspension, then are put into togerther glue with fresh American Ginseng
Body mill, mashing；
Step 3): the fresh American Ginseng slurries in step 2 are crossed into homogenizer, the pressure of homogeneous is 10 megapascal, homogenization cycles 2
It is secondary, the fresh American Ginseng slurries after obtaining homogeneous；
Step 4): American Ginseng slurries fresh in step 3 are crossed into high pressure homogenizer, the pressure of homogeneous is 50 megapascal or more, obtains height
Fresh American Ginseng slurries after pressing homogeneous, fresh American Ginseng slurries obtain fresh ginseng powder through low temperature spray drying, and spray drying goes out
At 30 DEG C, the diameter of fresh ginseng powder is 200nm for draught temperature control.
Step 5): fresh ginseng powder is discharged in the environment that relative humidity is 10%, then tabletting.
The measurement of ABA content in the fresh American ginseng buccal tablet of embodiment 4
1 instrument and reagent
The ten a ten thousandth electronics day LC-20A type high performance liquid chromatograph (Japanese Shimadzu, SPD-20A UV detector) BP211D
Flat (German Sartorious company).Abscisic acid reference substance is purchased from Sigma Co., USA, and purity > 98%, methanol is chromatographically pure,
Water is Wahaha Pure Water, other reagents are that analysis is pure.
Fresh American ginseng buccal tablet used in this experiment is self-control.
Method and result
The preparation of 2.1 solution
2.1.1 reference substance solution preparation precision weighs 5.51 mg of abscisic acid reference substance, sets in 50 mL volumetric flasks, adds 80%
Methanol makes it dissolve and is diluted to scale, shakes up, and obtaining concentration is 0.1102 mgmL-1Reference substance solution.
2.1.2 test solution respectively takes suitable sample, is put into the mortar of pre-cooling, and appropriate -20 DEG C of pre-coolings are added
80% methanol, ground sample to paste, is then added the methanol of 25 mL80% pre-cooling, extracts three times in 4 DEG C, soak every time repeatedly
The time mentioned is respectively 8 h, 4 h, 4 h, merges extracting solution three times, filters, water phase is concentrated filtrate to, with hydrochloric acid tune
PH to 2.8-3.0 is added ethyl acetate and extracts 2 times, obtains ethyl acetate phase, ethyl acetate phase is concentrated to dryness, then use
80% methanol constant volume crosses 0.45 μm of filter membrane into 10 mL volumetric flasks to get sample solution.It is stored in 4 DEG C of refrigerators, it is standby
With.
2.2 chromatographic conditions and system suitability test chromatographic column: Dalian Yi Lite HypersilODS2(250 mm ×
4.6 mm, 5 μm)；Column temperature: 45 DEG C；Mobile phase: -0.2% phosphate aqueous solution of methanol (55:45)；Flow velocity: 0.8 mLmin-1；
Detection wavelength: 260 nm；Sample volume: 20 μ L.Abscisic acid retention time under above-mentioned chromatographic condition, in sample and reference substance
Almost the same, theoretical cam curve is all larger than 3000.
The content of abscisic acid is 7.7mg/kg to the assay of 2.3 samples in fresh American ginseng buccal tablet after measured.
The anti-fatigue active of the fresh American ginseng buccal tablet of embodiment 5 is tested
By table it can be seen that abscisic acid and American ginseng buccal tablet high and low dose group have antifatigue activity.
Note: compared with the control group,# P<0.05,## P<0.01。
Claims (7)
1. a kind of preparation method of fresh American ginseng buccal tablet, which is characterized in that the weight percent of the component of the fresh American ginseng buccal tablet
Number are as follows: fresh ginseng powder 50-100%, water-soluble cellulose 0-10%, corrigent 0-1% or more, vegetable fat powder 0-40%, organic acid 0-
2%, plant polyose 0-10%, magnesium sulfate 0-1%, magnesium stearate 0-1%.
2. the preparation method of the fresh American ginseng buccal tablet according to claim 1, which is characterized in that including the following steps:
Step 1): the full fresh American Ginseng of juice is selected, cut into serving pieces, slice thickness 3-5cm are cleaned；
Step 2): the ratio of fresh American Ginseng and water is put into colloid mill according to the ratio of 1:2-8, is beaten, fresh American Ginseng slurry is obtained
Liquid, such as water-soluble fibre, corrigent, vegetable fat powder, organic acid, plant polyose component must be added, it can be first by these component water
It dissolves or adds water and stirs as uniform suspension, then be beaten together with fresh American Ginseng；
Step 3): the fresh American Ginseng slurries in step 2 are crossed into homogenizer, homogenization cycles are 2-3 times, the fresh west after obtaining homogeneous
American ginseng slurries；
Step 4): American Ginseng slurries fresh in step 3 are crossed into high pressure homogenizer, obtain it is high-pressure homogeneous after fresh American Ginseng slurries,
Fresh American Ginseng slurries obtain fresh ginseng powder through low temperature spray drying or freeze-drying;
Step 5): the fresh ginseng powder tabletting that step 4 is obtained is to get fresh American ginseng buccal tablet.
3. the preparation method of fresh American ginseng buccal tablet according to claim 1, which is characterized in that water-soluble fibre can be Ah
Draw one of primary galactan, inulin, chitosan or two or more mixtures.
4. the preparation method of fresh American ginseng buccal tablet according to claim 2, which is characterized in that the pressure of homogeneous in step 3
Power is 0-10 megapascal, and the high-pressure homogeneous pressure in step 4 is 50-500 megapascal.
5. the lozenge obtained according to the preparation method of the fresh American ginseng buccal tablet described in claim 2, which is characterized in that fresh in lozenge
The diameter of ginseng powder is 10-300nm.
6. the lozenge obtained according to the preparation method of the fresh American ginseng buccal tablet described in claim 2, which is characterized in that fresh in lozenge
The retention rate of ginseng powder effective component is greater than 95%.
7. the fresh American ginseng buccal tablet obtained according to the preparation method of the fresh American ginseng buccal tablet described in claim 2, which is characterized in that
The content of abscisic acid is 3.1-15.5mg/kg in fresh ginseng powder in step 4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811560942.XA CN109619559A (en) | 2018-12-20 | 2018-12-20 | A kind of preparation method and production technology of fresh American ginseng buccal tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811560942.XA CN109619559A (en) | 2018-12-20 | 2018-12-20 | A kind of preparation method and production technology of fresh American ginseng buccal tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109619559A true CN109619559A (en) | 2019-04-16 |
Family
ID=66075770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811560942.XA Pending CN109619559A (en) | 2018-12-20 | 2018-12-20 | A kind of preparation method and production technology of fresh American ginseng buccal tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109619559A (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09103275A (en) * | 1995-10-09 | 1997-04-22 | Riken Vitamin Co Ltd | Tablet confection containing galenical extract-compounded microcapsule |
| CN1312109A (en) * | 2001-03-12 | 2001-09-12 | 谢春生 | American ginseng buccal tablet and its preparation method |
| CN101653468A (en) * | 2008-08-22 | 2010-02-24 | 孙敬兰 | american ginseng buccal tablet |
| CN102077946A (en) * | 2010-11-09 | 2011-06-01 | 福建省力菲克药业有限公司 | Method for preparing nano American ginseng buccal tablets |
| CN102406679A (en) * | 2011-11-30 | 2012-04-11 | 中山市中智药业集团有限公司 | Traditional Chinese medicine American ginseng buccal tablet |
| CN104544106A (en) * | 2015-02-24 | 2015-04-29 | 刘永 | Preparation method of panacis quinquefolii radix chewable tablet |
| CN105580952A (en) * | 2014-10-20 | 2016-05-18 | 威海新异生物科技有限公司 | American ginseng tableting candy production method |
| CN106615152A (en) * | 2016-09-29 | 2017-05-10 | 黑龙江省农业科学院食品加工研究所 | Milk tablets having health-care efficacies of fresh American ginseng and preparation method of milk tablets |
| CN106983779A (en) * | 2017-03-31 | 2017-07-28 | 泸州德高生物科技有限公司 | The ecological oral freeze-dried powder, preparation method thereof of American Ginseng |
-
2018
- 2018-12-20 CN CN201811560942.XA patent/CN109619559A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09103275A (en) * | 1995-10-09 | 1997-04-22 | Riken Vitamin Co Ltd | Tablet confection containing galenical extract-compounded microcapsule |
| CN1312109A (en) * | 2001-03-12 | 2001-09-12 | 谢春生 | American ginseng buccal tablet and its preparation method |
| CN101653468A (en) * | 2008-08-22 | 2010-02-24 | 孙敬兰 | american ginseng buccal tablet |
| CN102077946A (en) * | 2010-11-09 | 2011-06-01 | 福建省力菲克药业有限公司 | Method for preparing nano American ginseng buccal tablets |
| CN102406679A (en) * | 2011-11-30 | 2012-04-11 | 中山市中智药业集团有限公司 | Traditional Chinese medicine American ginseng buccal tablet |
| CN105580952A (en) * | 2014-10-20 | 2016-05-18 | 威海新异生物科技有限公司 | American ginseng tableting candy production method |
| CN104544106A (en) * | 2015-02-24 | 2015-04-29 | 刘永 | Preparation method of panacis quinquefolii radix chewable tablet |
| CN106615152A (en) * | 2016-09-29 | 2017-05-10 | 黑龙江省农业科学院食品加工研究所 | Milk tablets having health-care efficacies of fresh American ginseng and preparation method of milk tablets |
| CN106983779A (en) * | 2017-03-31 | 2017-07-28 | 泸州德高生物科技有限公司 | The ecological oral freeze-dried powder, preparation method thereof of American Ginseng |
Non-Patent Citations (1)
| Title |
|---|
| 席会平 等: "《食品加工机械与设备》", 31 December 2014, 中国农业大学出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA014234B1 (en) | Composition for the treatment of hepatitis c or dietary supplement for prevention or alleviation hepatitis c symptoms | |
| CN106984414A (en) | The wall-breaking method of peony pollen | |
| CN102119992B (en) | Pharmaceutical preparation prepared from fresh motherwort and fresh aloe and preparation method thereof | |
| Peng et al. | Response surface modeling and optimization of ultrasound-assisted extraction of three flavonoids from tartary buckwheat (Fagopyrum tataricum) | |
| CN102397309A (en) | Fermentation method for ginseng and fermentative ginseng obtained by same | |
| CN112791126B (en) | Peony pistil extract and preparation method and application thereof | |
| CN109619555A (en) | A kind of preparation method and production technology of fresh Radix Notoginseng powder | |
| CN108904563B (en) | Processing method and application of whole-plant ginseng raw stock | |
| CN109528803A (en) | A kind of preparation method of Radix Pseudostellariae extract and its Radix Pseudostellariae extract and detection method of preparation | |
| CN105535112A (en) | Extraction technology of hypoglycemic medicinal active substances of mulberry leaves and mulberries and formula | |
| CN106879904A (en) | A kind of preparation method of yam drink | |
| CN105815707A (en) | Green kumquat powder as well as preparation method and purpose thereof | |
| CN107048295A (en) | A kind of peony pollen buccal tablet and preparation method thereof | |
| CN104187587A (en) | Edible fungus healthcare oral liquid and preparing method thereof | |
| CN107929544A (en) | The preparation method and applications of militarine positions and monomer in bletilla platymiscium | |
| CN109619554A (en) | A kind of preparation method and production technology of fresh ginseng powder | |
| CN107751303A (en) | A kind of green bean biscuits and its processing method rich in gamma aminobutyric acid | |
| CN109619559A (en) | A kind of preparation method and production technology of fresh American ginseng buccal tablet | |
| CN109619558A (en) | A kind of preparation method and production technology of fresh ginseng powder | |
| CN109619556A (en) | A kind of preparation method and production technology of fresh pilose antler powder | |
| CN109619475A (en) | A kind of preparation method of fresh black fruit Sorbus alnifloria powder | |
| RU2409381C1 (en) | Pharmaceutical composition for blood sugar and fat control, its manufacturing and administration thereof | |
| CN109619557A (en) | A kind of preparation method and production technology of fresh ginseng lozenge | |
| CN113322298A (en) | Biological limit value determination method for Qingjin phlegm-resolving decoction | |
| CN109619427A (en) | A kind of preparation method and production technology of fresh green soy bean powder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190416 |